Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Increased Incidence of Autoimmune and Infectious Diseases Among a Large Group of Diffuse Large B-Cell Lymphoma (DLBCL) Survivors: A Population-Based Study

Tanaya Shree, MD PhD, Qian Li, MS, Sally L. Glaser, PhD, Holden T. Maecker, PhD, Robert W. Haile, PhD MPH, Ronald Levy, MD, Theresa H.M. Keegan, PhD MS

Blood (2017) 130 (Supplement 1): 198.

https://doi.org/10.1182/blood.V130.Suppl_1.198.198

Published: 2017

Journal Articles

How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation

Alpana Waghmare, Janet A. Englund, Michael Boeckh

Blood (2016) 127 (22): 2682–2692.

https://doi.org/10.1182/blood-2016-01-634873

Published: 2016

Includes: Supplemental data

Journal Articles

Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation: Comparison with Viral Infectious Pneumonia

Sachiko Seo, MD PhD, Jeffrey Yu, Isaac C Jenkins, MS, Terry L Stevens-Ayers, MS, Kuypers M Jane, PhD, Huang Meei-Li, PhD, Wendy M Leisenring, PhD, Keith R Jerome, MD PhD, Sophie Paczesny, MD PhD, Michael Boeckh, MD

Blood (2015) 126 (23): 1927.

https://doi.org/10.1182/blood.V126.23.1927.1927

Published: 2015

Journal Articles

Response-Adapted Sequential Azacitidine and Induction Chemotherapy in Patients > 60 Years Old with Newly Diagnosed AML Eligible for Chemotherapy (RAS-AZIC): Results of the Phase I of the DRKS00004519 Study

Haifa Kathrin Al-Ali, MD, Rainer Krahl, PhD, Michael Cross, PhD, Hubert Karolin, Mrs, Nadja Jaekel, MD, Dietger Niederwieser, MD

Blood (2014) 124 (21): 2310.

https://doi.org/10.1182/blood.V124.21.2310.2310

Published: 2014

Journal Articles

Characteristics and Outcomes Of Patients With Down Syndrome Associated Acute Lymphoblastic Leukaemia Treated On UKALL 2003

Katharine Patrick, FRCPath, Rachel Wade, MSc, Nicholas Goulden, Clare Rowntree, FRCPath, Rachael Hough, FRCPath, Christopher D Mitchell, FRCPCH, Ajay J Vora

Blood (2013) 122 (21): 56.

https://doi.org/10.1182/blood.V122.21.56.56

Published: 2013

Journal Articles

Infectious Complications in Patients with Relapsed Acute Myeloid Leukemia (AML) Receiving Clofarabine Versus Fludarabine-Containing Salvage Chemotherapy Regimens

Michael S Mathisen, PharmD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MD, Stefan Faderl, MD, Gautam Borthakur, M.D., Jorge E. Cortes, MD, Alfonso Quintas-Cardama, MD

Blood (2012) 120 (21): 4322.

https://doi.org/10.1182/blood.V120.21.4322.4322

Published: 2012

Journal Articles

The Detection of Viral Infection in Bronchoalveolar Lavage Samples Collected From Recipients of Allogeneic Haematological Stem Cell Transplantation with Pneumonia (A 3 Year Epidemiological Study 2008–2010)

Eva Stepanova, Jr., MD, Pavel Zak, MD, PhD, Alzbeta Zavrelova, MD, Melanie Cermanova, MD, PHD, Jakub Radocha, MD, Lenka Pliskova, Sr., MD, Vlasta Stepanova, MD, Lukas Smolej, M.D., Ph.D.

Blood (2011) 118 (21): 4577.

https://doi.org/10.1182/blood.V118.21.4577.4577

Published: 2011

Journal Articles

Results of a Phase I Open-Label Study of Decitabine in Combination with Midostaurin (PKC412) for Elderly (Age ≥ 60) Newly Diagnosed or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia,

Casey B Williams, Pharm.D., Suman Kambhampati, MD, Siddhartha Ganguly, MD, Omar S. Aljitawi, MD, Ruben Reyes, MD, Allan Fleming, MD, Kapil N. Bhalla, MD, Sunil Abhyankar, MD, Joseph McGuirk, DO

Blood (2011) 118 (21): 3610.

https://doi.org/10.1182/blood.V118.21.3610.3610

Published: 2011

Journal Articles

Efficacy and Toxicity of Dose-Reduced Bortezomib/Dexamethasone Chemotherapy In Patients with High Risk Cardiac Light Chain Amyloidosis (Mayo Clinic stage III)

Stefan O Schonland, MD, Tilmann Bochtler, MD, Anthony D. Ho, MD, Ute Hegenbart, MD

Blood (2010) 116 (21): 1960.

https://doi.org/10.1182/blood.V116.21.1960.1960

Published: 2010

Journal Articles

A Study of Factors Influencing Outcome In Patients with Haematological Malignancy Requiring High Dependency Support In a Large UK Haematology and Bone Marrow Transplant Centre

Satarupa Choudhuri, Tim Somervaille, Phil Haji Michael, Mike Dennis

Blood (2010) 116 (21): 4732.

https://doi.org/10.1182/blood.V116.21.4732.4732

Published: 2010

Journal Articles

Risk Factors for Developing Human Herpes Virus-6 Encephalitis and Clinical Significance of Antiviral Therapy In Early Phase After Allogeneic Hematopoietic Stem Cell Transplantation.

Ayumi Numata, MD, Masatsugu Tanaka, MD, Takayoshi Tachibana, MD, Yoshiaki Ishigatsubo, MD, Atsuo Maruta, MD, Heiwa Kanamori, MD

Blood (2010) 116 (21): 4538.

https://doi.org/10.1182/blood.V116.21.4538.4538

Published: 2010

Journal Articles

Phase II Trial of Weekly Bortezomib in Combination with Rituximab in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia.

Irene M. Ghobrial, M.D., Fangxin Hong, PhD, Swaminathan Padmanabhan, MD, Ashraf Z. Badros, MD, Meghan Rourke, Renee Leduc, Stacey Chuma, Janet Kunsman, NP, Diane Warren, Brianna Harris, Amy Sam, Kenneth C. Anderson, MD, Paul Richardson, M.D., Ph.D., Steven Treon, MD, PhD, Edie Weller, PhD, Jeffrey Matous

Blood (2009) 114 (22): 2727.

https://doi.org/10.1182/blood.V114.22.2727.2727

Published: 2009

Journal Articles

90 .y-Ibritumomab Tiuxetan (Zevalin®) May Enhance Anti-Lymphoma Effect of Reduced-Intensity Fludarabine and Melphalan Regimen in Patients with Relapsed, Refractory B-Cell Non-Hodgkin Lymphoma (NHL) Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT).

Auayporn P. Nademanee, MD, Andrew Raubitschek, MD, Joycelynne Palmer, PHD, Dave Yamauchi, MD, Maria Delioukina, MD, Leslie Popplewell, MD, Firoozeh Sahebi, MD, Eileen Smith, MD, Anthony Stein, MD, Neil Kogut, MD, Margaret O'Donnell, MD, Stephen J Forman, MD

Blood (2009) 114 (22): 3357.

https://doi.org/10.1182/blood.V114.22.3357.3357

Published: 2009

Journal Articles

Pre-Autologous Stem Cell Transplantation (ASCT) Treatment with Rituximab Does Not Impair Stem Cell Harvest and Engraftment in Untreated Patients with Diffuse Large B-Cell Lymphoma (B-DLCL) at Poor Prognosis.

Blood (2005) 106 (11): 2738.

https://doi.org/10.1182/blood.V106.11.2738.2738

Published: 2005

NARROW

Increased Incidence of Autoimmune and Infectious Diseases Among a Large Group of Diffuse Large B-Cell Lymphoma (DLBCL) Survivors: A Population-Based Study

How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation

Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation: Comparison with Viral Infectious Pneumonia

Response-Adapted Sequential Azacitidine and Induction Chemotherapy in Patients > 60 Years Old with Newly Diagnosed AML Eligible for Chemotherapy (RAS-AZIC): Results of the Phase I of the DRKS00004519 Study

Characteristics and Outcomes Of Patients With Down Syndrome Associated Acute Lymphoblastic Leukaemia Treated On UKALL 2003

Infectious Complications in Patients with Relapsed Acute Myeloid Leukemia (AML) Receiving Clofarabine Versus Fludarabine-Containing Salvage Chemotherapy Regimens

The Detection of Viral Infection in Bronchoalveolar Lavage Samples Collected From Recipients of Allogeneic Haematological Stem Cell Transplantation with Pneumonia (A 3 Year Epidemiological Study 2008–2010)

Results of a Phase I Open-Label Study of Decitabine in Combination with Midostaurin (PKC412) for Elderly (Age ≥ 60) Newly Diagnosed or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia,

Efficacy and Toxicity of Dose-Reduced Bortezomib/Dexamethasone Chemotherapy In Patients with High Risk Cardiac Light Chain Amyloidosis (Mayo Clinic stage III)

A Study of Factors Influencing Outcome In Patients with Haematological Malignancy Requiring High Dependency Support In a Large UK Haematology and Bone Marrow Transplant Centre

Risk Factors for Developing Human Herpes Virus-6 Encephalitis and Clinical Significance of Antiviral Therapy In Early Phase After Allogeneic Hematopoietic Stem Cell Transplantation.

Phase II Trial of Weekly Bortezomib in Combination with Rituximab in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia.

90 .y-Ibritumomab Tiuxetan (Zevalin®) May Enhance Anti-Lymphoma Effect of Reduced-Intensity Fludarabine and Melphalan Regimen in Patients with Relapsed, Refractory B-Cell Non-Hodgkin Lymphoma (NHL) Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT).

Pre-Autologous Stem Cell Transplantation (ASCT) Treatment with Rituximab Does Not Impair Stem Cell Harvest and Engraftment in Untreated Patients with Diffuse Large B-Cell Lymphoma (B-DLCL) at Poor Prognosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only